IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 61 filers reported holding IMMUNE DESIGN CORP in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $9,000 | -50.0% | 1,615 | -88.4% | 0.00% | – |
| Q4 2018 | $18,000 | -67.3% | 13,927 | -12.1% | 0.00% | – |
| Q3 2018 | $55,000 | +243.8% | 15,853 | +374.6% | 0.00% | – |
| Q2 2018 | $16,000 | +45.5% | 3,340 | +3.3% | 0.00% | – |
| Q1 2018 | $11,000 | -15.4% | 3,233 | +0.6% | 0.00% | – |
| Q4 2017 | $13,000 | -23.5% | 3,215 | +100.7% | 0.00% | – |
| Q3 2017 | $17,000 | +325.0% | 1,602 | +154.3% | 0.00% | – |
| Q1 2017 | $4,000 | -20.0% | 630 | -29.1% | 0.00% | – |
| Q4 2016 | $5,000 | +400.0% | 888 | +1133.3% | 0.00% | – |
| Q3 2016 | $1,000 | – | 72 | +132.3% | 0.00% | – |
| Q4 2015 | $0 | -100.0% | 31 | -93.6% | 0.00% | – |
| Q3 2015 | $6,000 | -73.9% | 482 | -57.9% | 0.00% | – |
| Q2 2015 | $23,000 | – | 1,146 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 1,236,394 | $5,626,000 | 8.66% |
| Versant Venture Management, LLC | 2,208,210 | $10,047,356,000 | 3.14% |
| EcoR1 Capital, LLC | 4,437,600 | $20,191,000 | 1.92% |
| BVF INC/IL | 4,158,353 | $18,921,000 | 1.85% |
| Abingworth LLP | 352,300 | $1,621,000 | 0.93% |
| DAFNA Capital Management LLC | 328,500 | $1,495,000 | 0.70% |
| Bain Capital Public Equity Management, LLC | 1,221,368 | $5,557,000 | 0.38% |
| Portolan Capital Management | 444,875 | $2,024,000 | 0.21% |
| Telemetry Investments, L.L.C. | 113,500 | $516,000 | 0.20% |
| C M BIDWELL & ASSOCIATES LTD | 13,055 | $59,000 | 0.06% |